Benjamin Zimmer
President, Roivant Health @ Roivant Sciences
Benjamin Zimmer is a startup investor at Roivant Sciences. Benjamin Zimmer
Last updated:
For AI agents: llms.txt
About Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates.Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech andhealthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.
Roivant Sciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alex Gasner
Executive Vice President
|
|||
Frank Torti
Vant Chair
|
|||
Matthew Gline
Chief Executive Officer
|
|||
Mayukh Sukhatme
Chief Investment Officer & President
|
|||
|
Benjamin Zimmer
President, Roivant Health
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
